0001607062-18-000350.txt : 20181015
0001607062-18-000350.hdr.sgml : 20181015
20181015161720
ACCESSION NUMBER: 0001607062-18-000350
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181003
FILED AS OF DATE: 20181015
DATE AS OF CHANGE: 20181015
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Purcell Richard David Jr.
CENTRAL INDEX KEY: 0001639306
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-25169
FILM NUMBER: 181122397
MAIL ADDRESS:
STREET 1: 65 FAIR HAVEN ROAD
CITY: FAIR HAVEN
STATE: NJ
ZIP: 07704
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP
CENTRAL INDEX KEY: 0001059784
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 820490211
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0731
BUSINESS ADDRESS:
STREET 1: 10102 USA TODAY WAY
CITY: MIRAMAR
STATE: FL
ZIP: 33025
BUSINESS PHONE: 416-364-2551
MAIL ADDRESS:
STREET 1: 10102 USA TODAY WAY
CITY: MIRAMAR
STATE: FL
ZIP: 33025
4
1
ownership.xml
X0306
4
2018-10-03
0
0001059784
GENEREX BIOTECHNOLOGY CORP
GNBT
0001639306
Purcell Richard David Jr.
10102 USA TODAY WAY
MIRAMAR
FL
33025
1
1
0
0
SVP of Research & Drug Develop
Stock Option (right to buy)
2.23
2018-10-03
4
A
0
4500
0
A
2028-10-03
Common Stock
4500
4500
D
The option vests in three equal annual installments beginning on October 3, 2018.
/s/ Richard David Purcell, Jr.
2018-10-15